All Title Author
Keywords Abstract


Endovascular Thrombectomy Following Acute Ischemic Stroke: A Single-Center Case Series and Critical Review of the Literature

DOI: 10.3390/brainsci3020521

Keywords: acute ischemic stroke, endovascular, mechanical thrombectomy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Acute ischemic stroke (AIS) due to thrombo-embolic occlusion in the cerebral vasculature is a major cause of morbidity and mortality in the United States and throughout the world. Although the prognosis is poor for many patients with AIS, a variety of strategies and devices are now available for achieving recanalization in patients with this disease. Here, we review the treatment options for cerebrovascular thromboembolic occlusion with a focus on the evolution of strategies and devices that are utilized for achieving endovascular clot extraction. In order to demonstrate the progression of this treatment strategy over the past decade, we will also present a single-center case series of AIS patients treated with endovascular thrombectomy.

References

[1]  Haley, E.C.; Lyden, P.D.; Johnston, K.C.; Hemmen, T.M. TNK in Stroke Investigators A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 2005, 36, 607–612, doi:10.1161/01.STR.0000154872.73240.e9.
[2]  Roger, V.L.; Go, A.S.; Lloyd-Jones, D.M.; Benjamin, E.J.; Berry, J.D.; Borden, W.B.; Bravata, D.M.; Dai, S.; Ford, E.S.; Fox, C.S.; et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Executive summary: Heart disease and stroke statistics—2012 update: A report from the American Heart Association. Circulation 2012, 125, 188–197, doi:10.1161/CIR.0b013e3182456d46.
[3]  Liberatore, G.T.; Samson, A.; Bladin, C.; Schleuning, W.-D.; Medcalf, R.L. Vampire bat salivary plasminogen activator (desmoteplase): A unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke 2003, 34, 537–543, doi:10.1161/01.STR.0000049764.49162.76.
[4]  Del Zoppo, G.J.; Higashida, R.T.; Furlan, A.J.; Pessin, M.S.; Rowley, H.A.; Gent, M. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998, 29, 4–11, doi:10.1161/01.STR.29.1.4.
[5]  Qureshi, A.I.; Ali, Z.; Suri, M.F.; Kim, S.H.; Shatla, A.A.; Ringer, A.J.; Lopes, D.K.; Guterman, L.R.; Hopkins, L.N. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery 2001, 49, 41–48; discussion 48–50.
[6]  Lapchak, P.A.; Araujo, D.M.; Pakola, S.; Song, D.; Wei, J.; Zivin, J.A. Microplasmin: A novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 2002, 33, 2279–2284, doi:10.1161/01.STR.0000028267.09604.7B.
[7]  Adams, H.P.; Leclerc, J.R.; Bluhmki, E.; Clarke, W.; Hansen, M.D.; Hacke, W. Measuring outcomes as a function of baseline severity of ischemic stroke. Cerebrovasc. Dis. 2004, 18, 124–129, doi:10.1159/000079260.
[8]  Junghans, U.; Seitz, R.J.; Aulich, A.; Freund, H.J.; Siebler, M. Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: An open pilot study. Cerebrovasc. Dis. 2001, 12, 308–312, doi:10.1159/000047726.
[9]  Junghans, U.; Seitz, R.J.; Ritzl, A.; Wittsack, H.-J.; Fink, G.R.; Freund, H.J.; Siebler, M. Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban. Neurology 2002, 58, 474–476, doi:10.1212/WNL.58.3.474.
[10]  Nogueira, R.G.; Schwamm, L.H.; Hirsch, J.A. Endovascular approaches to acute stroke, part 1: Drugs, devices, and data. AJNR Am. J. Neuroradiol. 2009, 30, 649–661, doi:10.3174/ajnr.A1486.
[11]  Rosamond, W.; Flegal, K.; Friday, G.; Furie, K.; Go, A.; Greenlund, K.; Haase, N.; Ho, M.; Howard, V.; Kissela, B.; et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics—2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115, e69–e171, doi:10.1161/CIRCULATIONAHA.106.179918.
[12]  Furlan, A.; Higashida, R.; Wechsler, L.; Gent, M.; Rowley, H.; Kase, C.; Pessin, M.; Ahuja, A.; Callahan, F.; Clark, W.M.; et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999, 282, 2003–2011, doi:10.1001/jama.282.21.2003.
[13]  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 1995, 333, 1581–1587, doi:10.1056/NEJM199512143332401.
[14]  Jahan, R.; Duckwiler, G.R.; Kidwell, C.S.; Sayre, J.W.; Gobin, Y.P.; Villablanca, J.P.; Saver, J.; Starkman, S.; Martin, N.; Vi?uela, F. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am. J. Neuroradiol. 1999, 20, 1291–1299.
[15]  Caplan, L.R.; Mohr, J.P.; Kistler, J.P.; Koroshetz, W. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis—not a panacea for ischemic stroke. N. Engl. J. Med. 1997, 337, 1309–1310; discussion 1313, doi:10.1056/NEJM199710303371812.
[16]  Ueda, T.; Sakaki, S.; Yuh, W.T.; Nochide, I.; Ohta, S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J. Cereb. Blood Flow Metab. 1999, 19, 99–108.
[17]  Saver, J.L. Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: Novel derivation method and application to thrombolytic therapy for acute stroke. Arch. Neurol. 2004, 61, 1066–1070, doi:10.1001/archneur.61.7.1066.
[18]  Pillai, J.J.; Lanzieri, C.F.; Trinidad, S.B.; Tarr, R.W.; Sunshine, J.L.; Lewin, J.S. Initial angiographic appearance of intracranial vascular occlusions in acute stroke as a predictor of outcome of thrombolysis: Initial experience. Radiology 2001, 218, 733–738.
[19]  Hacke, W.; Donnan, G.; Fieschi, C.; Kaste, M.; von Kummer, R.; Broderick, J.P.; Brott, T.; Frankel, M.; Grotta, J.C.; Haley, E.C.; et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004, 363, 768–774, doi:10.1016/S0140-6736(04)15692-4.
[20]  Arnold, M.; Schroth, G.; Nedeltchev, K.; Loher, T.; Remonda, L.; Stepper, F.; Sturzenegger, M.; Mattle, H.P. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002, 33, 1828–1833, doi:10.1161/01.STR.0000020713.89227.B7.
[21]  Rha, J.-H.; Saver, J.L. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007, 38, 967–973, doi:10.1161/01.STR.0000258112.14918.24.
[22]  Berlis, A.; Lutsep, H.; Barnwell, S.; Norbash, A.; Wechsler, L.; Jungreis, C.A.; Woolfenden, A.; Redekop, G.; Hartmann, M.; Schumacher, M. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004, 35, 1112–1116, doi:10.1161/01.STR.0000124126.17508.d3.
[23]  Lewandowski, C.A.; Frankel, M.; Tomsick, T.A.; Broderick, J.; Frey, J.; Clark, W.; Starkman, S.; Grotta, J.; Spilker, J.; Khoury, J.; Brott, T. Combined intravenous and intra-arterial r-TPA venous intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999, 30, 2598–2605, doi:10.1161/01.STR.30.12.2598.
[24]  Kleindorfer, D.; Lindsell, C.J.; Brass, L.; Koroshetz, W.; Broderick, J.P. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 2008, 39, 924–928, doi:10.1161/STROKEAHA.107.490375.
[25]  Sundt, T.M.; Smith, H.C.; Campbell, J.K.; Vlietstra, R.E.; Cucchiara, R.F.; Stanson, A.W. Transluminal angioplasty for basilar artery stenosis. Mayo Clin. Proc. 1980, 55, 673–680.
[26]  Tomsick, T.; Broderick, J.; Carrozella, J.; Khatri, P.; Hill, M.; Palesch, Y.; Khoury, J. Interventional Management of Stroke II Investigators Revascularization results in the Interventional Management of Stroke II trial. AJNR Am. J. Neuroradiol. 2008, 29, 582–587, doi:10.3174/ajnr.A0843.
[27]  IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke 2004, 35, 904–911, doi:10.1161/01.STR.0000121641.77121.98.
[28]  IMS II Trial Investigators. The Interventional Management of Stroke (IMS) II Study. Stroke 2007, 38, 2127–2135, doi:10.1161/STROKEAHA.107.483131.
[29]  Hacke, W.; Kaste, M.; Bluhmki, E.; Brozman, M.; Dávalos, A.; Guidetti, D.; Larrue, V.; Lees, K.R.; Medeghri, Z.; Machnig, T.; et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 2008, 359, 1317–1329, doi:10.1056/NEJMoa0804656.
[30]  Khatri, P.; Hill, M.D.; Palesch, Y.Y.; Spilker, J.; Jauch, E.C.; Carrozzella, J.A.; Demchuk, A.M.; Martin, R.; Mauldin, P.; Dillon, C.; et al. Methodology of the Interventional Management of Stroke III Trial. Int. J. Stroke 2008, 3, 130–137, doi:10.1111/j.1747-4949.2008.00151.x.
[31]  Del Zoppo, G.J.; Saver, J.L.; Jauch, E.C.; Adams, H.P.; American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the American Heart Association/American Stroke Association. Stroke 2009, 40, 2945–2948, doi:10.1161/STROKEAHA.109.192535.
[32]  Phatouros, C.C.; Higashida, R.T.; Malek, A.M.; Smith, W.S.; Mully, T.W.; DeArmond, S.J.; Dowd, C.F.; Halbach, V.V. Endovascular stenting of an acutely thrombosed basilar artery: Technical case report and review of the literature. Neurosurgery 1999, 44, 667–673, doi:10.1097/00006123-199903000-00134.
[33]  Kleindorfer, D.; Kissela, B.; Schneider, A.; Woo, D.; Khoury, J.; Miller, R.; Alwell, K.; Gebel, J.; Szaflarski, J.; Pancioli, A.; et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study. Stroke 2004, 35, e27–e29, doi:10.1161/01.STR.0000109767.11426.17.
[34]  Nakano, S.; Iseda, T.; Yoneyama, T.; Kawano, H.; Wakisaka, S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: An alternative option to intra-arterial thrombolysis. Stroke 2002, 33, 2872–2876, doi:10.1161/01.STR.0000038985.26269.F2.
[35]  Nogueira, R.G.; Schwamm, L.H.; Buonanno, F.S.; Koroshetz, W.J.; Yoo, A.J.; Rabinov, J.D.; Pryor, J.C.; Hirsch, J.A. Low-pressure balloon angioplasty with adjuvant pharmacological therapy in patients with acute ischemic stroke caused by intracranial arterial occlusions. Neuroradiology 2008, 50, 331–340, doi:10.1007/s00234-007-0340-z.
[36]  Levy, E.I.; Siddiqui, A.H.; Crumlish, A.; Snyder, K.V.; Hauck, E.F.; Fiorella, D.J.; Hopkins, L.N.; Mocco, J. First Food and Drug Administration-approved prospective trial of primary intracranial stenting for acute stroke: SARIS (stent-assisted recanalization in acute ischemic stroke). Stroke 2009, 40, 3552–3556, doi:10.1161/STROKEAHA.109.561274.
[37]  Booth, N.A.; Robbie, L.A.; Croll, A.M.; Bennett, B. Lysis of platelet-rich thrombi: The role of PAI-1. Ann. N. Y. Acad. Sci. 1992, 667, 70–80, doi:10.1111/j.1749-6632.1992.tb51599.x.
[38]  Brommer, E.J.; Potter van Loon, B.J.; Rijken, D.C.; van Bockel, J.H. Composition and susceptibility to thrombolysis of pathological human arterial thrombi. Ann. N. Y. Acad. Sci. 1992, 667, 283–285, doi:10.1111/j.1749-6632.1992.tb51627.x.
[39]  Gobin, Y.P.; Starkman, S.; Duckwiler, G.R.; Grobelny, T.; Kidwell, C.S.; Jahan, R.; Pile-Spellman, J.; Segal, A.; Vi?uela, F.; Saver, J.L. MERCI 1: A phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004, 35, 2848–2854, doi:10.1161/01.STR.0000147718.12954.60.
[40]  Broderick, J.P.; Palesch, Y.Y.; Demchuk, A.M.; Yeatts, S.D.; Khatri, P.; Hill, M.D.; Jauch, E.C.; Jovin, T.G.; Yan, B.; Silver, F.L.; et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 2013, 368, 893–903, doi:10.1056/NEJMoa1214300.
[41]  Xavier, A.R.; Tiwari, A.; Kansara, A. Angioplasty and stenting for mechanical thrombectomy in acute ischemic stroke. Neurology 2012, 79, S142–S147, doi:10.1212/WNL.0b013e3182695896.
[42]  Roubec, M.; Kuliha, M.; Procházka, V.; Krajca, J.; Czerny, D.; Jonszta, T.; Krajina, A.; Sanák, D.; Langová, K.; Herzig, R.; Skoloudík, D. A Controlled Trial of Revascularization in Acute Stroke. Radiology 2012, 266, 871–878.
[43]  Smith, W.S.; Sung, G.; Starkman, S.; Saver, J.L.; Kidwell, C.S.; Gobin, Y.P.; Lutsep, H.L.; Nesbit, G.M.; Grobelny, T.; Rymer, M.M.; et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005, 36, 1432–1438, doi:10.1161/01.STR.0000171066.25248.1d.
[44]  Smith, W.S.; Sung, G.; Saver, J.; Budzik, R.; Duckwiler, G.; Liebeskind, D.S.; Lutsep, H.L.; Rymer, M.M.; Higashida, R.T.; Starkman, S.; et al. Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 2008, 39, 1205–1212, doi:10.1161/STROKEAHA.107.497115.
[45]  Mayer, T.E.; Hamann, G.F.; Brueckmann, H. Mechanical extraction of a basilar-artery embolus with the use of flow reversal and a microbasket. N. Engl. J. Med. 2002, 347, 769–770, doi:10.1056/NEJM200209053471019.
[46]  Brekenfeld, C.; Schroth, G.; El-Koussy, M.; Nedeltchev, K.; Reinert, M.; Slotboom, J.; Gralla, J. Mechanical thromboembolectomy for acute ischemic stroke: Comparison of the catch thrombectomy device and the Merci Retriever in vivo. Stroke 2008, 39, 1213–1219, doi:10.1161/STROKEAHA.107.495614.
[47]  Henkes, H.; Reinartz, J.; Lowens, S.; Miloslavski, E.; Roth, C.; Reith, W.; Kühne, D. A device for fast mechanical clot retrieval from intracranial arteries (Phenox clot retriever). Neurocrit. Care 2006, 5, 134–140, doi:10.1385/NCC:5:2:134.
[48]  Schumacher, H.C.; Meyers, P.M.; Yavagal, D.R.; Harel, N.Y.; Elkind, M.S.V.; Mohr, J.P.; Pile-Spellman, J. Endovascular mechanical thrombectomy of an occluded superior division branch of the left MCA for acute cardioembolic stroke. Cardiovasc. Intervent. Radiol. 2003, 26, 305–308, doi:10.1007/s00270-003-2719-5.
[49]  Henkes, H.; Lowens, S.; Preiss, H.; Reinartz, J.; Miloslavski, E.; Kühne, D. A new device for endovascular coil retrieval from intracranial vessels: Alligator retrieval device. AJNR Am. J. Neuroradiol. 2006, 27, 327–329.
[50]  Kerber, C.W.; Wanke, I.; Bernard, J.; Woo, H.H.; Liu, M.W.; Nelson, P.K. Rapid intracranial clot removal with a new device: The alligator retriever. AJNR Am. J. Neuroradiol. 2007, 28, 860–863.
[51]  Bose, A.; Henkes, H.; Alfke, K.; Reith, W.; Mayer, T.E.; Berlis, A.; Branca, V.; Sit, S.P.; Penumbra Phase 1 Stroke Trial Investigators. The Penumbra System: A mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am. J. Neuroradiol. 2008, 29, 1409–1413, doi:10.3174/ajnr.A1110.
[52]  Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: Safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009, 40, 2761–2768, doi:10.1161/STROKEAHA.108.544957.
[53]  Tarr, R.; Hsu, D.; Kulcsar, Z.; Bonvin, C.; Rufenacht, D.; Alfke, K.; Stingele, R.; Jansen, O.; Frei, D.; Bellon, R.; et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J. Neurointerv. Surg. 2010, 2, 341–344, doi:10.1136/jnis.2010.002600.
[54]  Ellis, J.A.; Youngerman, B.E.; Higashida, R.T.; Altschul, D.; Meyers, P.M. Endovascular treatment strategies for acute ischemic stroke. Int. J. Stroke 2011, 6, 511–522, doi:10.1111/j.1747-4949.2011.00670.x.
[55]  A Randomized, Concurrent Controlled Trial to Assess the Safety and Effectiveness of the Separator 3D as a Component of the Penumbra System in the Revascularization of Large Vessel Occlusion in Acute Ischemic Stroke. Available online: http://clinicaltrials.gov/show/NCT01584609 (accessed on 3 January 2013).
[56]  Assess the Penumbra System in the Treatment of Acute Stroke (THERAPY). Available online: http://clinicaltrials.gov/show/NCT01429350 (accessed on 3 January 2013).
[57]  Saver, J.L.; Jahan, R.; Levy, E.I.; Jovin, T.G.; Baxter, B.; Nogueira, R.G.; Clark, W.; Budzik, R.; Zaidat, O.O.; SWIFT Trialists. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): A randomized, parallel-group, non-inferiority trial. Lancet 2012, 380, 1241–1249, doi:10.1016/S0140-6736(12)61384-1.
[58]  Nogueira, R.G.; Lutsep, H.L.; Gupta, R.; Jovin, T.G.; Albers, G.W.; Walker, G.A.; Liebeskind, D.S.; Smith, W.S.; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): A randomised trial. Lancet 2012, 380, 1231–1240, doi:10.1016/S0140-6736(12)61299-9.
[59]  Mendon?a, N.; Flores, A.; Pagola, J.; Rubiera, M.; Rodríguez-Luna, D.; Miquel, M.A.D.; Cardona, P.; Quesada, H.; Mora, P.; Alvarez-Sabín, J.; et al. Trevo versus Solitaire a Head-to-Head Comparison between Two Heavy Weights of Clot Retrieval. J. Neuroimaging 2012, doi:10.1111/j.1552-6569.2012.00730.x.
[60]  Ciccone, A.; Valvassori, L.; Nichelatti, M.; Sgoifo, A.; Ponzio, M.; Sterzi, R.; Boccardi, E.; SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N. Engl. J. Med. 2013, 368, 904–913, doi:10.1056/NEJMoa1213701.
[61]  Kidwell, C.S.; Jahan, R.; Gornbein, J.; Alger, J.R.; Nenov, V.; Ajani, Z.; Feng, L.; Meyer, B.C.; Olson, S.; Schwamm, L.H.; et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N. Engl. J. Med. 2013, 368, 914–923, doi:10.1056/NEJMoa1212793.

Full-Text

comments powered by Disqus